| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-868-60 | 67877-868 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 15 mg/1 | 60 CAPSULE in 1 BOTTLE (67877-868-60) |
| 67877-869-05 | 67877-869 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 25 mg/1 | 500 CAPSULE in 1 BOTTLE (67877-869-05) |
| 67877-869-33 | 67877-869 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 25 mg/1 | 1 BLISTER PACK in 1 CARTON (67877-869-33) / 10 CAPSULE in 1 BLISTER PACK |
| 67877-869-60 | 67877-869 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 25 mg/1 | 60 CAPSULE in 1 BOTTLE (67877-869-60) |
| 67877-868-33 | 67877-868 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 15 mg/1 | 1 BLISTER PACK in 1 CARTON (67877-868-33) / 10 CAPSULE in 1 BLISTER PACK |
| 67877-868-05 | 67877-868 | HUMAN PRESCRIPTION DRUG | Topiramate | Topiramate | CAPSULE | ORAL | 20240625 | N/A | ANDA | ANDA218482 | Ascend Laboratories, LLC | TOPIRAMATE | 15 mg/1 | 500 CAPSULE in 1 BOTTLE (67877-868-05) |